1. Home
  2. CVKD vs AWX Comparison

CVKD vs AWX Comparison

Compare CVKD & AWX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CVKD
  • AWX
  • Stock Information
  • Founded
  • CVKD 2022
  • AWX 1998
  • Country
  • CVKD United States
  • AWX United States
  • Employees
  • CVKD N/A
  • AWX N/A
  • Industry
  • CVKD Medicinal Chemicals and Botanical Products
  • AWX Environmental Services
  • Sector
  • CVKD Health Care
  • AWX Utilities
  • Exchange
  • CVKD Nasdaq
  • AWX Nasdaq
  • Market Cap
  • CVKD 8.2M
  • AWX 8.6M
  • IPO Year
  • CVKD 2023
  • AWX 1998
  • Fundamental
  • Price
  • CVKD $0.43
  • AWX $2.18
  • Analyst Decision
  • CVKD Strong Buy
  • AWX
  • Analyst Count
  • CVKD 2
  • AWX 0
  • Target Price
  • CVKD $3.50
  • AWX N/A
  • AVG Volume (30 Days)
  • CVKD 79.4K
  • AWX 5.3K
  • Earning Date
  • CVKD 08-12-2024
  • AWX 08-09-2024
  • Dividend Yield
  • CVKD N/A
  • AWX N/A
  • EPS Growth
  • CVKD N/A
  • AWX N/A
  • EPS
  • CVKD N/A
  • AWX N/A
  • Revenue
  • CVKD N/A
  • AWX $80,999,000.00
  • Revenue This Year
  • CVKD N/A
  • AWX N/A
  • Revenue Next Year
  • CVKD N/A
  • AWX N/A
  • P/E Ratio
  • CVKD N/A
  • AWX N/A
  • Revenue Growth
  • CVKD N/A
  • AWX N/A
  • 52 Week Low
  • CVKD $0.36
  • AWX $1.76
  • 52 Week High
  • CVKD $2.17
  • AWX $2.66
  • Technical
  • Relative Strength Index (RSI)
  • CVKD 42.55
  • AWX 48.57
  • Support Level
  • CVKD $0.43
  • AWX $2.10
  • Resistance Level
  • CVKD $0.49
  • AWX $2.26
  • Average True Range (ATR)
  • CVKD 0.02
  • AWX 0.08
  • MACD
  • CVKD -0.00
  • AWX 0.01
  • Stochastic Oscillator
  • CVKD 0.00
  • AWX 36.58

About CVKD Cadrenal Therapeutics Inc.

Cadrenal Therapeutics Inc is focused on developing a novel therapy with orphan drug indication, tecarfarin, for the prevention of systemic thromboembolism (blood clots) of cardiac origin in patients with end-stage renal disease (on dialysis) and atrial fibrillation (irregular heartbeat) or AFib. Tecarfarin is an anticoagulant designed using a drug design process that targets a different pathway than most commonly prescribed drugs for the treatment of thrombosis and AFib.

About AWX Avalon Holdings Corporation

Avalon Holdings Corp is a waste management company. The company provides waste management services to industrial, commercial, municipal, and governmental customers in selected northeastern and midwestern U.S. markets. The company has two operating segments. The Waste management services segment which is the key revenue driver, includes waste disposal services, captive landfill operations, and saltwater injection well operations. Its Golf and related operations segment includes management of golf courses and related clubhouses, a hotel, fitness centers, tennis courts, salon and spa services, dining, banquet, and conference facilities.

Share on Social Networks: